IL-2 antibodies in type 1 diabetes and during IL-2 therapy

Guillaume Churlaud; Michelle Rosenzwajg; Patrice Cacoub; David Saadoun; Dominique Valteau-Couanet; Nathalie Chaput; Alberto Pugliese; David Klatzmann

doi:10.1007/s00125-018-4649-4

IL-2 antibodies in type 1 diabetes and during IL-2 therapy

Guillaume Churlaud, Michelle Rosenzwajg, Patrice Cacoub, David Saadoun, Dominique Valteau-Couanet, Nathalie Chaput, Alberto Pugliese, David Klatzmann

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

5 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	2066-2068
Nombre de pages	3
journal	Diabetologia
Volume	61
Numéro de publication	9
Les DOIs	https://doi.org/10.1007/s00125-018-4649-4
état	Publié - 1 sept. 2018

Accès au document

10.1007/s00125-018-4649-4

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{1b145f6ab3e64c86a373a947c5f6571c,

title = "IL-2 antibodies in type 1 diabetes and during IL-2 therapy",

keywords = "Autoantibodies, Autoimmune disease, Autoimmunity, IL-2, Type 1 diabetes",

author = "Guillaume Churlaud and Michelle Rosenzwajg and Patrice Cacoub and David Saadoun and Dominique Valteau-Couanet and Nathalie Chaput and Alberto Pugliese and David Klatzmann",

note = "Funding Information: Funding This study was supported by institutional funding by the AP-HP, Sorbonne Universit{\'e} and INSERM, by the DIABIL-2 FP7 research grant (number 305380), by the grant NB-GD2: DGOS: TRANSLA 12-109; INCA: 2012-057 and Canc{\'e}rop{\^o}le: 2012-1-RT-10-IGR-01.",

year = "2018",

month = sep,

day = "1",

doi = "10.1007/s00125-018-4649-4",

language = "English",

volume = "61",

pages = "2066--2068",

journal = "Diabetologia",

issn = "0012-186X",

number = "9",

}

TY - JOUR

T1 - IL-2 antibodies in type 1 diabetes and during IL-2 therapy

AU - Churlaud, Guillaume

AU - Rosenzwajg, Michelle

AU - Cacoub, Patrice

AU - Saadoun, David

AU - Valteau-Couanet, Dominique

AU - Chaput, Nathalie

AU - Pugliese, Alberto

AU - Klatzmann, David

N1 - Funding Information: Funding This study was supported by institutional funding by the AP-HP, Sorbonne Université and INSERM, by the DIABIL-2 FP7 research grant (number 305380), by the grant NB-GD2: DGOS: TRANSLA 12-109; INCA: 2012-057 and Cancéropôle: 2012-1-RT-10-IGR-01.

PY - 2018/9/1

Y1 - 2018/9/1

KW - Autoantibodies

KW - Autoimmune disease

KW - Autoimmunity

KW - IL-2

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85047911511&partnerID=8YFLogxK

U2 - 10.1007/s00125-018-4649-4

DO - 10.1007/s00125-018-4649-4

M3 - Article

C2 - 29860627

AN - SCOPUS:85047911511

SN - 0012-186X

VL - 61

SP - 2066

EP - 2068

JO - Diabetologia

JF - Diabetologia

IS - 9

ER -